Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.
about
Towards tumor immunodiagnosticsThe network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancerErythropoietin drives breast cancer progression by activation of its receptor EPORThe tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma.The Globalization of Cooperative Groups.Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury.Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo.Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.Human Cancer Cells Signal Their Competitive Fitness Through MYC ActivityMYC overexpression with its prognostic and clinicopathological significance in breast cancer.
P2860
Q26738691-35B80869-E3D7-4F00-B771-11D5540E2AA0Q26785448-28E00A1B-7E0D-4BD8-8F6D-40D628B1A755Q33888764-76353CA2-77B9-4EBC-82CA-043516418812Q33905746-2887DA8A-808E-4A73-925B-39D19307076FQ36119749-5BD15E57-33D0-4B45-8DE3-A036FEF038FDQ37635473-10946D98-CFBB-4A5A-8D01-BC99431D8BF1Q38382577-92087A68-F4E1-49CB-898C-00297EA824DAQ38661390-8C8A582E-73A2-4DD3-B284-2E135961A987Q39615956-09273A4A-0042-47ED-9F32-A19C5F448D96Q42282618-81144F3B-6035-446A-A2A1-CF6807E70D22Q47356965-80979376-0CF0-41E4-963A-BAAD7DC474A6
P2860
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of c-MYC protein expres ...... uzumab NCCTG (alliance) N9831.
@en
Impact of c-MYC protein expres ...... ith adjuvant trastuzumab NCCTG
@nl
type
label
Impact of c-MYC protein expres ...... uzumab NCCTG (alliance) N9831.
@en
Impact of c-MYC protein expres ...... ith adjuvant trastuzumab NCCTG
@nl
prefLabel
Impact of c-MYC protein expres ...... uzumab NCCTG (alliance) N9831.
@en
Impact of c-MYC protein expres ...... ith adjuvant trastuzumab NCCTG
@nl
P2093
P2860
P1476
Impact of c-MYC protein expres ...... tuzumab NCCTG (alliance) N9831
@en
P2093
Ann E McCullough
Beiyun Chen
Darren Riehle
Edith A Perez
George W Sledge
James N Ingle
Julie Gralow
Karla Ballman
Kathleen Tenner
Leila A Kutteh
P2860
P304
P356
10.1158/1078-0432.CCR-13-0558
P407
P50
P577
2013-08-21T00:00:00Z